A review now published in the Journal of Experimental & Clinical Cancer Research offers ... Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from ...

platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have previously been treated with between one and three prior systemic treatment regimens can be treated ...

Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women over 50. Screening is highly recommended in women with ...

The study enrolled adults with platinum-resistant, FRα-expressing high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior systemic ...

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of ...

Progression-free survival (PFS) and second PFS (PFS2) by disease stage in patients (pts) with homologous recombination deficiency (HRD)-positive newly diagnosed advanced ovarian cancer receiving ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...